TipRanks
Scinai Immunotherapeutics (DE:2F50)
FRANKFURT:2F50

Compare Scinai Immunotherapeutics (2F50) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Scinai Immunotherapeutics
€2.26
€709.52K
―
-90.09%
―
GT Biopharma
$0.29
$12.41M
-0.06
-55.87%
1 Buy
0 Hold
0 Sell
Moderate Buy
Aditxt
$0.04
$3.89M
―
-100.00%
―
CERo Therapeutics Holdings
$0.01
$850.90K
―
-99.80%
―
Psyence Biomedical
$4.32
$20.71M
-0.43
-72.70%
―
CDT Equity
$1.89
$1.63M
―
-100.00%
―

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:2F50
Scinai Immunotherapeutics
2.26
-20.54
-90.09%
GTBP
GT Biopharma
6.47
-9.50
-59.49%
ADTX
Aditxt
0.04
-18,550.04
-100.00%
CERO
CERo Therapeutics Holdings
0.01
-5.38
-99.81%
PBM
Psyence Biomedical
5.46
-15.10
-73.45%
CDT
CDT Equity
1.36
-33,968.64
-100.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts